Title | Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Sušac B, Ling L, Leiner I, Pamer EG |
Journal | Cell Host Microbe |
Volume | 18 |
Issue | 1 |
Pagination | 27-37 |
Date Published | 2015 Jul 08 |
ISSN | 1934-6069 |
Keywords | Animals, Clostridium difficile, Clostridium Infections, Disease Resistance, Immunity, Innate, Lymphocyte Subsets, Mice, Inbred C57BL, Mice, Knockout, Survival Analysis |
Abstract | Infection with the opportunistic enteric pathogen Clostridium difficile is an increasingly common clinical complication that follows antibiotic treatment-induced gut microbiota perturbation. Innate lymphoid cells (ILCs) are early responders to enteric pathogens; however, their role during C. difficile infection is undefined. To identify immune pathways that mediate recovery from C. difficile infection, we challenged C57BL/6, Rag1(-/-) (which lack T and B cells), and Rag2(-/-)Il2rg(-/-) (Ragγc(-/-)) mice (which additionally lack ILCs) with C. difficile. In contrast to Rag1(-/-) mice, ILC-deficient Ragγc(-/-) mice rapidly succumbed to infection. Rag1(-/-) but not Ragγc(-/-) mice upregulate expression of ILC1- or ILC3-associated proteins following C. difficile infection. Protection against infection was restored by transferring ILCs into Ragγc(-/-) mice. While ILC3s made a minor contribution to resistance, loss of IFN-γ or T-bet-expressing ILC1s in Rag1(-/-) mice increased susceptibility to C. difficile. These data demonstrate a critical role for ILC1s in defense against C. difficile. |
DOI | 10.1016/j.chom.2015.06.011 |
Alternate Journal | Cell Host Microbe |
PubMed ID | 26159718 |
PubMed Central ID | PMC4537644 |
Grant List | T32GM007739 / GM / NIGMS NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States R01 AI095706 / AI / NIAID NIH HHS / United States AI095706 / AI / NIAID NIH HHS / United States / / Howard Hughes Medical Institute / United States R01 AI042135 / AI / NIAID NIH HHS / United States T32 GM007739 / GM / NIGMS NIH HHS / United States |
Submitted by kej2006 on June 6, 2018 - 4:09pm